171 related articles for article (PubMed ID: 27506406)
21. Expression study of the target receptor tyrosine kinase of Imatinib mesylate in skull base chordomas.
Orzan F; Terreni MR; Longoni M; Boari N; Mortini P; Doglioni C; Riva P
Oncol Rep; 2007 Jul; 18(1):249-52. PubMed ID: 17549375
[TBL] [Abstract][Full Text] [Related]
22. Endoscopic endonasal removal of laterally extended clival chordoma using side-viewing scopes.
Taniguchi M; Kohmura E
Acta Neurochir (Wien); 2012 Apr; 154(4):627-32. PubMed ID: 22083851
[TBL] [Abstract][Full Text] [Related]
23. Brachyury gene copy number gain and activation of the PI3K/Akt pathway: association with upregulation of oncogenic Brachyury expression in skull base chordoma.
Otani R; Mukasa A; Shin M; Omata M; Takayanagi S; Tanaka S; Ueki K; Saito N
J Neurosurg; 2018 May; 128(5):1428-1437. PubMed ID: 28753115
[TBL] [Abstract][Full Text] [Related]
24. Disease outcomes for skull base and spinal chordomas: a single center experience.
Ahmed R; Sheybani A; Menezes AH; Buatti JM; Hitchon PW
Clin Neurol Neurosurg; 2015 Mar; 130():67-73. PubMed ID: 25590662
[TBL] [Abstract][Full Text] [Related]
25. Clinical characteristics, immunohistochemistry, and outcomes of 77 patients with skull base chordomas.
Ouyang T; Zhang N; Zhang Y; Jiao J; Ren J; Huang T; Chen J
World Neurosurg; 2014; 81(5-6):790-7. PubMed ID: 23298670
[TBL] [Abstract][Full Text] [Related]
26. Expanded endoscopic endonasal approach for treatment of clival chordomas: early results in 12 patients.
Dehdashti AR; Karabatsou K; Ganna A; Witterick I; Gentili F
Neurosurgery; 2008 Aug; 63(2):299-307; discussion 307-9. PubMed ID: 18797360
[TBL] [Abstract][Full Text] [Related]
27. Male sex as a risk factor for the clinical course of skull base chordomas.
Rachinger W; Eigenbrod S; Dützmann S; Simon M; Feigl GC; Kremenevskaja N; Kretzschmar H; Zausinger S; Kreth FW; Thon N; Tonn JC
J Neurosurg; 2014 Jun; 120(6):1313-20. PubMed ID: 24405075
[TBL] [Abstract][Full Text] [Related]
28. SNF5 as a prognostic factor in skull base chordoma.
Li M; Zhai Y; Bai J; Wang S; Gao H; Li C; Gui S; Du J; Zhang Y
J Neurooncol; 2018 Mar; 137(1):139-146. PubMed ID: 29222701
[TBL] [Abstract][Full Text] [Related]
29. Current comprehensive management of cranial base chordomas: 10-year meta-analysis of observational studies.
Di Maio S; Temkin N; Ramanathan D; Sekhar LN
J Neurosurg; 2011 Dec; 115(6):1094-105. PubMed ID: 21819197
[TBL] [Abstract][Full Text] [Related]
30. Tyrosine kinase receptor expression in chordomas: phosphorylated AKT correlates inversely with outcome.
de Castro CV; Guimaraes G; Aguiar S; Lopes A; Baiocchi G; da Cunha IW; Campos AH; Soares FA; Begnami MD
Hum Pathol; 2013 Sep; 44(9):1747-55. PubMed ID: 23618355
[TBL] [Abstract][Full Text] [Related]
31. Clival chordomas: clinical management, results, and complications in 71 patients.
Sen C; Triana AI; Berglind N; Godbold J; Shrivastava RK
J Neurosurg; 2010 Nov; 113(5):1059-71. PubMed ID: 19929198
[TBL] [Abstract][Full Text] [Related]
32. An unusual presentation of clival chordoma: a case report and review of the literature.
Andijani M; Jamjoom A; Togersen A; Ram B; Bodkin P; Kamel M
Br J Neurosurg; 2020 Oct; 34(5):549-551. PubMed ID: 31226887
[TBL] [Abstract][Full Text] [Related]
33. Surgical results of an endoscopic endonasal approach for clival chordomas.
Saito K; Toda M; Tomita T; Ogawa K; Yoshida K
Acta Neurochir (Wien); 2012 May; 154(5):879-86. PubMed ID: 22402876
[TBL] [Abstract][Full Text] [Related]
34. Removal of clival chordoma in an adolescent thorough combned pterional transsylvian and anterior temporal approach.
Bozbuğa M; Turan Süslü H; Güler I; Bilgi B; Bayindir C
Turk Neurosurg; 2007; 17(1):55-9. PubMed ID: 17918681
[TBL] [Abstract][Full Text] [Related]
35. A 13-year patient journey of infant giant clival chordoma: case report and literature review.
Apps J; Gagen R; Neumann E; Solanki G; English M
Childs Nerv Syst; 2023 Apr; 39(4):1077-1081. PubMed ID: 36414866
[TBL] [Abstract][Full Text] [Related]
36. The Significance of Intraoperative Magnetic Resonance Imaging in Resection of Skull Base Chordomas.
Metwali H; Samii A; Gerganov V; Giordano M; Fahlbusch R; Samii M
World Neurosurg; 2019 Aug; 128():e185-e194. PubMed ID: 31003024
[TBL] [Abstract][Full Text] [Related]
37. Brachyury: A sensitive marker, but not a prognostic factor, for skull base chordomas.
Wang K; Tian K; Wang L; Wu Z; Ren C; Hao S; Feng J; Li J; Wan H; Jia G; Zhang L; Zhang J
Mol Med Rep; 2015 Sep; 12(3):4298-4304. PubMed ID: 26099340
[TBL] [Abstract][Full Text] [Related]
38. Experimental study on differences in clivus chordoma bone invasion: an iTRAQ-based quantitative proteomic analysis.
Wu Z; Wang L; Guo Z; Wang K; Zhang Y; Tian K; Zhang J; Sun W; Yu C
PLoS One; 2015; 10(3):e0119523. PubMed ID: 25793716
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical expression of receptor tyrosine kinase PDGFR-α, c-Met, and EGFR in skull base chordoma.
Akhavan-Sigari R; Abili M; Gaab MR; Rohde V; Zafar N; Emami P; Ostertag H
Neurosurg Rev; 2015 Jan; 38(1):89-98; discussion 98-9. PubMed ID: 25323095
[TBL] [Abstract][Full Text] [Related]
40. Predictive Value of Transforming Growth Factor-α and Ki-67 for the Prognosis of Skull Base Chordoma.
Zhang S; Bai J; Li M; Zhai Y; Wang S; Liu Q; Li C; Gui S; Zhang Y
World Neurosurg; 2019 Sep; 129():e199-e206. PubMed ID: 31125781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
